Abstract
Introduction: Probiotics are defined as live microorganisms, which when administered in adequate amounts, confer a health benefit on the host. Health benefits have mainly been demonstrated for specific probiotic strains of the following genera: Lactobacillus, Bifidobacterium, Saccharomyces, Enterococcus, Streptococcus, Pediococcus, Leuconostoc and Bacillus. The human microbiota is getting a lot of attention today and research has already demonstrated that alteration of this microbiota may have far-reaching consequences. One of the possible routes for correcting dysbiosis is by consuming probiotics. Methods: In this research we investigated the influence of potentially pathogenic challenge bacteria Pseudomonas aeruginosa on multispecies probiotic food supplement and kefir microbiota. The probiotics included various strains of the species Lactobacillus acidophilus, Lactobacillus reuteri, Lactobacillus rhamnosus, Lactobacillus delbrueckii subs, bulgaricus, Lactobacillus plantarum, Lactobacillus lactis subs, lactis, Bifidobacterium bifidum, Bifidobacterium breve, Bifidobacterium longum, Streptococcus thermophilus, Enterococcus faecium. Samples of 40 mL of milk were prepared with added challenge potentially pathogenic Pseudomonas aeruginosa and 1 mL suspension of multispecies probiotics. All samples were incubated for 4 days. Results and discussion: It was found that both the multispecies probiotic supplement and the kefir microbiota with diverse microbial populations successfully decreased the concentration of challenge potentially pathogenic Pseudomonas aeruginosa for 3 log10 steps. On the other hand the antagonistic effect of the oligospecies probiotics with only three different probiotic species and the monospecies probiotic supplement against P. aeruginosa was not detected. These results show that multispecies microorganisms that create a live communities create a synergistic effect and effective complex interconnecting quorum-sensing regulatory networks that compete with a potentially pathogen bacteria. Conclusions: Although probiotic administration does not permanently modulate the intestinal microbiota, this does not mean that during acute disruption of the sensitive intestinal microbiota balance such as due to antibiotic consumption, transiently present probiotics do not aid the permanent intestinal microbiota in restoring this balance.
Highlights
Probiotics are defined as live microorganisms, which when administered in adequate amounts, confer a health benefit on the host
In this research we investigated the influence of potentially pathogenic challenge bacteria Pseudomonas aeruginosa on multispecies probiotic food supplement and kefir microbiota
On the other hand the antagonistic effect of the oligospecies probiotics with only three different probiotic species and the monospecies probiotic supplement against P. aeruginosa was not detected. These results show that multispecies microorganisms that create a live communities create a synergistic effect and effective complex interconnecting quorum-sensing regulatory networks that compete with a potentially pathogen bacteria
Summary
Probiotics are defined as live microorganisms, which when administered in adequate amounts, confer a health benefit on the host. Health benefits have mainly been demonstrated for specific probiotic strains of the following genera: Lactobacillus, Bifidobacterium, Saccharomyces, Enterococcus, Streptococcus, Pediococcus, Leuconostoc and Bacillus. By definition probiotic foods must contain live microorganisms that, when administered in adequate amounts confer a health benefit to the host [5]. The most common probiotic bacteria are certain strains from the genera Lactobacillus Lactis, Leuconostoc mesenteroides, Bacillus subtilis, Enterococcus faecium, Streptococcus thermophilus, Escherichia coli etc. Other probiotic bacteria include: Pediococcus acidilactici, Lactococcus lactis subsp. Certain yeasts such as Saccharomyces boulardii are probiotics [6]. Probiotics together with other beneficial microbes are commensals of the gut and differ from pathogenic bacteria in the terms of their actions on immune cells in the gut as they do not stimulate the proliferation of mononuclear cells or trigger an inflammatory action [7]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.